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SURGEON USES HIGH-POWERED 1’HEART LASER”
TO CREATE NEW CHANNELS UI PATIENTS’ BEATThJG HEARTS
Transmyocardial Revascularization (Ti’fR) Procedures
Performed Successfully at St. Luke’s Medical Center
MILWAUKEE, Wis., November 19, 1992

——

St. Luke’s Medical Center in

Milwaukee announced today the use of a high—powered laser to create new blood
flow channels in the beating heart of a 58—year--old Milwaukee man, suffering
from heart disease so extensive that bypass surgery was not possible.
This intense carbon dioxide laser, named The Heart Laser, is manufactured
by Laser Engineering Inc., a subsidiary of Massachusetts—based PLC Systems
Inc.

(AMEX: PLC, PLCE), following 20 years of research by St. Luke’s heart

surgeon Mahxnood Mirhoseini, M.D.

Mirhoseini’s procedure creates channels that

mimic the functioning of reptile hearts, which do not depend upon arteries to
circulate blood.

Instead, blood seeps through tiny spaces in the myocardium,

or outer heart muscle to nourish the heart.
It was Mirhoseini’s idea to use a laser to open channels in the human
heart to restore oxygen-rich blood flow.

This procedure, known as

Transmyocardial Revascularization (TMR), creates new channels for blood to
flow through the heart muscle.
“Many patients suffering from heart disease are not eligible or do not
respond to bypass surgery, angioplasty and/or medication management,” said
Mirhoseini.

“We anticipate this laser technique could offer new hope to

approximately 300,000 Americans who currently have no avenue of treatment for
their disease.”
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St. Luke’s Heart Laser/ADD 1

Mirhoseini began exploring the use of lasers to increase blood flow to the
heart in the late 1960s, prior to the widespread use of heart bypass surgery.
In addition to the experimental work, clinical studies were done to evaluate
the safety and effectiveness of laser channels in the heart.

Hirhoseini used

a low-powered carbon dioxide laser in conjunction with bypass surgery.

At the

same time he guided the development of PLC Systems’ high-powered laser that

The

could open blood circulation channels while the heart was beating.

high-powered Heart Laser alleviates the necessity of placing a patient on a
heart bypass machine, dramatically reducing time in surgery.
Surgeons access the heart through a left side chest incision, avoiding the
need to cut through the sternum and open the rib cage.

PLC Systems’
Each laser

computer—controlled laser fires between the patient’s heartbeats.

blast creates a permanent channel between the damaged area and the left
ventricle.

Oxygen—rich blood from the chamber now can reach, and constantly

infuse, the damaged tissue, improving its function.
About 15 channels, each the size of a pencil lead, are created.
fires when the left ventricle is full of blood.

The laser

This prevents the laser beam

from continuing through the heart, because carbon dioxide laser energy is
absorbed and dispersed by liquid.

The laser’s outer entry points into the

inyocardium close naturally, while the interior channels into the left
ventricle remain open.
Mirhoseini’s first patient underwent the two—hour surgery Tuesday, and a
The patients are expected to remain

second surgery was performed today.

hospitalized for an average of five days following surgery.
From Hirhoseini’s early TMR work that accompanied bypass surgery, 18 of
the 20 patients with end-stage heart disease remain alive today, an average of
Two of the patients subsequently died of

six years after the laser surgery.
unrelated causes.

Autopsy results revealed the laser channels had remained

open and formed vessel-like walls.
St. Luke’s Medical Center is one of four U.S. hospitals approved for Phase
II clinical trials of PLC Systems’ Heart Laser System.

The other three U.S.

hospital locations for the 50 FDA approved TMR procedures, are:

San Francisco

Heart Institute, Texas Heart Institute, in Houston, Brigham & Women’s Hospital
in Boston.
PLC Systems Inc. develops, manufactures and markets medical laser systems,
accessories and related surgical products.
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